Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with or without gallstones
- People with any degree of NAFLD (non-alcoholic fatty liver disease), ranging from none to severe
Who may not be able to join:
- People with serious health conditions or physical limitations that would prevent participation in a resistance exercise (strength training) program
- People who take medications that can change muscle mass, such as steroids (for example, corticosteroids)
- People with a history of hepatitis B or hepatitis C infection
- People who take medications that can cause liver damage
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Catterina Ferreccio, MD, Pontificia Universidad Catolica de Chile
Phone: +56 9 9219 6618
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Presence and severity of Non-Alcoholic Fatty liver Disease (NAFLD) at baseline and 12 month later.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.